ASX-listed Volpara Health Technologies, a global leader in software for the early detection of breast cancer, has reported a 34% increase in revenue from customer contracts to $35 million in the year ended March 31, 2023.
Volpara chief executive and managing director Teri Thomas, who was appointed
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
